ReviewCancer drug resistance (Alhambra, Calif.)2026

Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer.

Lijun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.